Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Regeneration of the Fibula with Unidirectional Porous Hydroxyapatite.

Demiya K, Kunisada T, Nakata E, Hasei J, Ozaki T.

Case Rep Orthop. 2019 Oct 13;2019:9024643. doi: 10.1155/2019/9024643. eCollection 2019.

2.

Flavonoids with Two OH Groups in the B-Ring Promote Pigmented Hair Regeneration.

Taguchi N, Yuriguchi M, Ando T, Kitai R, Aoki H, Kunisada T.

Biol Pharm Bull. 2019;42(9):1446-1449. doi: 10.1248/bpb.b19-00295.

3.

Characterization of a BAC transgenic mouse expressing Krt19-driven iCre recombinase in its digestive organs.

Kanayama T, Tomita H, Binh NH, Hatano Y, Aoki H, Okada H, Hirata A, Fujihara Y, Kunisada T, Hara A.

PLoS One. 2019 Aug 8;14(8):e0220818. doi: 10.1371/journal.pone.0220818. eCollection 2019.

4.

Choline-deficient-diet Decreases Fibroblasts in the Circulating Tumor Cell (CTC) Microenvironment.

Matsuura K, Suetsugu A, Satake T, Nakamura M, Kunisada T, Shimizu M, Hoffman RM.

Anticancer Res. 2019 Aug;39(8):4061-4064. doi: 10.21873/anticanres.13562.

PMID:
31366488
5.

Color-coded Imaging of the Fate of Cancer-cell-derived Exosomes During Pancreatic Cancer Metastases in a Nude-mouse Model.

Satake T, Suetsugu A, Nakamura M, Kunisada T, Saji S, Moriwaki H, Shimizu M, Hoffman RM.

Anticancer Res. 2019 Aug;39(8):4055-4060. doi: 10.21873/anticanres.13561.

PMID:
31366487
6.

Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan.

Nishida Y, Kawai A, Toguchida J, Ogose A, Ae K, Kunisada T, Matsumoto Y, Matsunobu T, Takahashi K, Nishida K, Ozaki T.

Int J Clin Oncol. 2019 Nov;24(11):1498-1505. doi: 10.1007/s10147-019-01512-z. Epub 2019 Jul 22.

PMID:
31332613
7.

Osteosarcoma in patients over 50 years of age: Multi-institutional retrospective analysis of 104 patients.

Nagano A, Matsumoto S, Kawai A, Okuma T, Hiraga H, Matsumoto Y, Nishida Y, Yonemoto T, Hosaka M, Takahashi M, Yoshikawa H, Kunisada T, Asanuma K, Naka N, Emori M, Kubo T, Kawashima H, Kawamoto T, Yokoyama R, Tsukushi S, Sato K, Okamoto T, Hiraoka K, Morioka H, Tanaka K, Takagi T, Iwamoto Y, Ozaki T.

J Orthop Sci. 2019 May 30. pii: S0949-2658(19)30128-9. doi: 10.1016/j.jos.2019.04.008. [Epub ahead of print]

PMID:
31155441
8.

Temporary External Fixation Can Stabilize Hip Transposition Arthroplasty After Resection of Malignant Periacetabular Bone Tumors.

Kunisada T, Fujiwara T, Hasei J, Nakata E, Senda M, Ozaki T.

Clin Orthop Relat Res. 2019 Aug;477(8):1892-1901. doi: 10.1097/CORR.0000000000000764.

PMID:
30985613
9.

Mini-open excision of osteoid osteoma using intraoperative O-arm/Stealth navigation.

Fujiwara T, Kunisada T, Takeda K, Hasei J, Nakata E, Mochizuki Y, Kiyono M, Yoshida A, Ozaki T.

J Orthop Sci. 2019 Mar;24(2):337-341. doi: 10.1016/j.jos.2018.09.017. Epub 2018 Oct 26.

PMID:
30857616
10.

Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.

Takeuchi A, Nomura A, Yamamoto N, Hayashi K, Igarashi K, Tandai S, Kawai A, Matsumine A, Miwa S, Nishida Y, Nakamura T, Terauchi R, Hoshi M, Kunisada T, Endo M, Yoshimura K, Murayama T, Tsuchiya H.

BMC Musculoskelet Disord. 2019 Feb 9;20(1):68. doi: 10.1186/s12891-019-2453-z.

11.

Sub-deltoid approach for removal of large lipoma around the proximal humerus: A report of three cases.

Hasei J, Kunisada T, Nakata E, Ozaki T.

J Orthop Sci. 2019 Feb 1. pii: S0949-2658(19)30009-0. doi: 10.1016/j.jos.2018.12.030. [Epub ahead of print] No abstract available.

PMID:
30718041
12.

Frequent mutations of genes encoding vacuolar H+ -ATPase components in granular cell tumors.

Sekimizu M, Yoshida A, Mitani S, Asano N, Hirata M, Kubo T, Yamazaki F, Sakamoto H, Kato M, Makise N, Mori T, Yamazaki N, Sekine S, Oda I, Watanabe SI, Hiraga H, Yonemoto T, Kawamoto T, Naka N, Funauchi Y, Nishida Y, Honoki K, Kawano H, Tsuchiya H, Kunisada T, Matsuda K, Inagaki K, Kawai A, Ichikawa H.

Genes Chromosomes Cancer. 2019 Jun;58(6):373-380. doi: 10.1002/gcc.22727. Epub 2019 Jan 21.

PMID:
30597645
13.

Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects.

Uehara T, Eikawa S, Nishida M, Kunisada Y, Yoshida A, Fujiwara T, Kunisada T, Ozaki T, Udono H.

Int Immunol. 2019 Mar 28;31(4):187-198. doi: 10.1093/intimm/dxy079.

14.

Reduction in human hair graying by sterubin, an active flavonoid of Eriodictyon angustifolium.

Taguchi N, Hata T, Kamiya E, Kobayashi A, Aoki H, Kunisada T.

J Dermatol Sci. 2018 Dec;92(3):286-289. doi: 10.1016/j.jdermsci.2018.11.002. Epub 2018 Nov 8. No abstract available.

PMID:
30514662
15.

Injury patterns of medial meniscus posterior root tears.

Furumatsu T, Okazaki Y, Okazaki Y, Hino T, Kamatsuki Y, Masuda S, Miyazawa S, Nakata E, Hasei J, Kunisada T, Ozaki T.

Orthop Traumatol Surg Res. 2019 Feb;105(1):107-111. doi: 10.1016/j.otsr.2018.10.001. Epub 2018 Nov 12.

PMID:
30442555
16.

Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.

Koike H, Nishida Y, Kohno K, Shimoyama Y, Motoi T, Hamada S, Kawai A, Ogose A, Ozaki T, Kunisada T, Matsumoto Y, Matsunobu T, Ae K, Gokita T, Sakai T, Shimizu K, Ishiguro N.

Hum Pathol. 2019 Feb;84:155-163. doi: 10.1016/j.humpath.2018.09.018. Epub 2018 Oct 5.

PMID:
30292627
17.

Color-coded Imaging of the Circulating Tumor Cell Microenvironment.

Satake T, Suetsugu A, Nakamura M, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2018 Oct;38(10):5635-5638. doi: 10.21873/anticanres.12898.

PMID:
30275181
18.

FGF2-responsive genes in human dental pulp cells assessed using a rat spinal cord injury model.

Sugiyama K, Nagashima K, Miwa T, Shimizu Y, Kawaguchi T, Iida K, Tamaoki N, Hatakeyama D, Aoki H, Abe C, Morita H, Kunisada T, Shibata T, Fukumitsu H, Tezuka KI.

J Bone Miner Metab. 2019 May;37(3):467-474. doi: 10.1007/s00774-018-0954-8. Epub 2018 Sep 5.

PMID:
30187276
19.

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.

Urakawa H, Yonemoto T, Matsumoto S, Takagi T, Asanuma K, Watanuki M, Takemoto A, Naka N, Matsumoto Y, Kawai A, Kunisada T, Kubo T, Emori M, Hiraga H, Hatano H, Tsukushi S, Nishida Y, Akisue T, Morii T, Takahashi M, Nagano A, Yoshikawa H, Sato K, Kawano M, Hiraoka K, Tanaka K, Iwamoto Y, Ozaki T.

World J Surg Oncol. 2018 Aug 8;16(1):160. doi: 10.1186/s12957-018-1459-6.

20.

Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.

Nakamura M, Suetsugu A, Hasegawa K, Satake T, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2018 Aug;38(8):4417-4423. doi: 10.21873/anticanres.12743.

PMID:
30061205
21.

Intraoperative O-arm-navigated resection in musculoskeletal tumors.

Fujiwara T, Kunisada T, Takeda K, Hasei J, Nakata E, Nakahara R, Yoshida A, Ozaki T.

J Orthop Sci. 2018 Nov;23(6):1045-1050. doi: 10.1016/j.jos.2018.06.012. Epub 2018 Jul 21.

PMID:
30037470
22.

Melanoblasts as Multipotent Cells in Murine Skin.

Motohashi T, Kunisada T.

Methods Mol Biol. 2019;1879:257-266. doi: 10.1007/7651_2018_144.

PMID:
30006864
23.

Direct Conversion of Mouse Embryonic Fibroblasts into Neural Crest Cells.

Motohashi T, Kunisada T.

Methods Mol Biol. 2019;1879:307-321. doi: 10.1007/7651_2018_145.

PMID:
29797008
24.

Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma.

Yoshida A, Fujiwara T, Uotani K, Morita T, Kiyono M, Yokoo S, Hasei J, Nakata E, Kunisada T, Ozaki T.

Acta Med Okayama. 2018 Apr;72(2):165-174. doi: 10.18926/AMO/55857.

25.

Differential Organ-targeting and Cellular Characteristics of Metastatic Human Pancreatic Cancer Cell Lines in Mouse Models.

Satake T, Suetsugu A, Nakamura M, Hasegawa K, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2018 Apr;38(4):1927-1935.

PMID:
29599308
26.

Patients with osteosarcoma and soft tissue sarcoma might become "cancer refugees" in some Japanese regional cities.

Yamane H, Kunisada T, Ozaki T, Ochi N, Honda Y, Nagasaki Y, Nakagawa N, Yamagishi T, Nakanishi H, Takigawa N.

Cancer Manag Res. 2018 Feb 19;10:353-359. doi: 10.2147/CMAR.S155282. eCollection 2018.

27.

Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma.

Uotani K, Fujiwara T, Yoshida A, Iwata S, Morita T, Kiyono M, Yokoo S, Kunisada T, Takeda K, Hasei J, Numoto K, Nezu Y, Yonemoto T, Ishii T, Kawai A, Ochiya T, Ozaki T.

Sci Rep. 2017 Nov 7;7(1):14634. doi: 10.1038/s41598-017-12660-5.

28.

Priming with FGF2 stimulates human dental pulp cells to promote axonal regeneration and locomotor function recovery after spinal cord injury.

Nagashima K, Miwa T, Soumiya H, Ushiro D, Takeda-Kawaguchi T, Tamaoki N, Ishiguro S, Sato Y, Miyamoto K, Ohno T, Osawa M, Kunisada T, Shibata T, Tezuka KI, Furukawa S, Fukumitsu H.

Sci Rep. 2017 Oct 18;7(1):13500. doi: 10.1038/s41598-017-13373-5.

29.

Induced haploinsufficiency of Kit receptor tyrosine kinase impairs brain development.

Aoki H, Hara A, Kunisada T.

JCI Insight. 2017 Oct 5;2(19). pii: 94385. doi: 10.1172/jci.insight.94385.

30.

Galectin-1 enhances the generation of neural crest cells.

Motohashi T, Nishioka M, Kitagawa D, Kawamura N, Watanabe N, Wakaoka T, Kadoya T, Kunisada T.

Int J Dev Biol. 2017;61(6-7):407-413. doi: 10.1387/ijdb.160380tm.

31.

Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.

Yamakawa Y, Tazawa H, Hasei J, Osaki S, Omori T, Sugiu K, Komatsubara T, Uotani K, Fujiwara T, Yoshida A, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T.

Cancer Sci. 2017 Sep;108(9):1870-1880. doi: 10.1111/cas.13316. Epub 2017 Aug 3.

32.

Imaging the Role of Multinucleate Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in Peritoneal Metastasis in Mouse Models.

Hasegawa K, Suetsugu A, Nakamura M, Matsumoto T, Aoki H, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2017 Jul;37(7):3435-3440.

PMID:
28668832
33.

Choline-Deficient-Diet-Induced Fatty Liver Is a Metastasis-Resistant Microenvironment.

Nakamura M, Suetsugu A, Hasegawa K, Matsumoto T, Aoki H, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2017 Jul;37(7):3429-3434.

PMID:
28668831
34.

Factors associated with the decision of operative procedure for proximal femoral bone metastasis: Questionnaire survey to institutions participating the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group.

Araki N, Chuman H, Matsunobu T, Tanaka K, Katagiri H, Kunisada T, Hiruma T, Hiraga H, Morioka H, Hatano H, Asanuma K, Nishida Y, Hiraoka K, Okamoto T, Abe S, Watanuki M, Morii T, Sugiura H, Yoshida Y, Ohno T, Outani H, Yokoyama K, Shimose S, Fukuda H, Iwamoto Y.

J Orthop Sci. 2017 Sep;22(5):938-945. doi: 10.1016/j.jos.2017.05.012. Epub 2017 Jun 17.

35.

Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies.

Takahashi M, Takahashi S, Araki N, Sugiura H, Ueda T, Yonemoto T, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Shimura M, Kawai A.

Oncologist. 2017 Aug;22(8):979-988. doi: 10.1634/theoncologist.2016-0064. Epub 2017 May 18.

36.

Genetic Recombination Between Stromal and Cancer Cells Results in Highly Malignant Cells Identified by Color-Coded Imaging in a Mouse Lymphoma Model.

Nakamura M, Suetsugu A, Hasegawa K, Matsumoto T, Aoki H, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

J Cell Biochem. 2017 Dec;118(12):4216-4221. doi: 10.1002/jcb.26068. Epub 2017 Jun 9.

PMID:
28419513
37.

Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.

Fujiwara T, Uotani K, Yoshida A, Morita T, Nezu Y, Kobayashi E, Yoshida A, Uehara T, Omori T, Sugiu K, Komatsubara T, Takeda K, Kunisada T, Kawamura M, Kawai A, Ochiya T, Ozaki T.

Oncotarget. 2017 May 16;8(20):33375-33392. doi: 10.18632/oncotarget.16498.

38.

Acremopeptin, a new peptaibol from Acremonium sp. PF1450.

Iijima M, Amemiya M, Sawa R, Kubota Y, Kunisada T, Momose I, Kawada M, Shibasaki M.

J Antibiot (Tokyo). 2017 Jun;70(6):791-794. doi: 10.1038/ja.2017.15. Epub 2017 Feb 15. No abstract available.

PMID:
28196979
39.

A rare manifestation of extraskeletal myxoid chondrosarcoma with a huge expanding hematoma.

Omori T, Fujiwara T, Kunisada T, Takeda K, Hasei J, Yoshida A, Yanai H, Ozaki T.

J Orthop Sci. 2019 Mar;24(2):377-381. doi: 10.1016/j.jos.2016.12.011. Epub 2017 Feb 8. No abstract available.

PMID:
28187993
40.

Cellular context-dependent consequences of Apc mutations on gene regulation and cellular behavior.

Hashimoto K, Yamada Y, Semi K, Yagi M, Tanaka A, Itakura F, Aoki H, Kunisada T, Woltjen K, Haga H, Sakai Y, Yamamoto T, Yamada Y.

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):758-763. doi: 10.1073/pnas.1614197114. Epub 2017 Jan 5.

41.

Neurological Recovery after Posterior Spinal Surgery in Patients with Metastatic Epidural Spinal Cord Compression.

Watanabe N, Sugimoto Y, Tanaka M, Mazaki T, Arataki S, Takigawa T, Kataoka M, Kunisada T, Ozaki T.

Acta Med Okayama. 2016 Dec;70(6):449-453.

42.

Disruption of Rest Leads to the Early Onset of Cataracts with the Aberrant Terminal Differentiation of Lens Fiber Cells.

Aoki H, Ogino H, Tomita H, Hara A, Kunisada T.

PLoS One. 2016 Sep 15;11(9):e0163042. doi: 10.1371/journal.pone.0163042. eCollection 2016.

43.

A Mouse Model of Fluorescent Protein-expressing Disseminated Peritoneal Lymphoma for Fluorescence-guided Surgery.

Matsumoto T, Suetsugu A, Hasegawa K, Nakamura M, Shibata Y, Aoki H, Kunisada T, Tsurumi H, Shimizu M, Bouvet M, Hoffman RM.

Anticancer Res. 2016 Sep;36(9):4483-7.

PMID:
27630285
44.

Color-coded Imaging Enables Fluorescence-guided Surgery to Resect the Tumor Along with the Tumor Microenvironment in a Syngeneic Mouse Model of EL-4 Lymphoma.

Hasegawa K, Suetsugu A, Nakamura M, Matsumoto T, Kunisada T, Shimizu M, Saji S, Moriwaki H, Bouvet M, Hoffman RM.

Anticancer Res. 2016 Sep;36(9):4443-8.

PMID:
27630280
45.

Color-coded Live Imaging of Heterokaryon Formation and Nuclear Fusion of Hybridizing Cancer Cells.

Suetsugu A, Matsumoto T, Hasegawa K, Nakamura M, Kunisada T, Shimizu M, Saji S, Moriwaki H, Bouvet M, Hoffman RM.

Anticancer Res. 2016 Aug;36(8):3827-31.

PMID:
27466484
46.

Pigmentation of regenerated hairs after wounding.

Yuriguchi M, Aoki H, Taguchi N, Kunisada T.

J Dermatol Sci. 2016 Oct;84(1):80-87. doi: 10.1016/j.jdermsci.2016.07.004. Epub 2016 Jul 6.

PMID:
27435302
47.

Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.

Morioka H, Takahashi S, Araki N, Sugiura H, Ueda T, Takahashi M, Yonemoto T, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Susa M, Nakayama R, Nishimoto K, Kikuta K, Horiuchi K, Kawai A.

BMC Cancer. 2016 Jul 14;16:479. doi: 10.1186/s12885-016-2511-y.

48.

Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas.

Osaki S, Tazawa H, Hasei J, Yamakawa Y, Omori T, Sugiu K, Komatsubara T, Fujiwara T, Sasaki T, Kunisada T, Yoshida A, Urata Y, Kagawa S, Ozaki T, Fujiwara T.

Sci Rep. 2016 Jun 30;6:28953. doi: 10.1038/srep28953.

49.

Imaging Nuclear-Cytoplasmic Dynamics in Primary and Metastatic Colon Cancer in Nude Mice.

Hasegawa K, Suetsugu A, Nakamura M, Matsumoto T, Aoki H, Kunisada T, Bouvet M, Shimizu M, Hoffman RM.

Anticancer Res. 2016 May;36(5):2113-7.

PMID:
27127111
50.

Color-Coded Imaging of Syngeneic Orthotopic Malignant Lymphoma Interacting with Host Stromal Cells During Metastasis.

Matsumoto T, Suetsugu A, Hasegawa K, Nakamura M, Aoki H, Kunisada T, Tsurumi H, Shimizu M, Hoffman RM.

Anticancer Res. 2016 Apr;36(4):1473-8.

PMID:
27069122

Supplemental Content

Loading ...
Support Center